Robert J. Perez
CIK: 0001263230
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Rapport Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 10, 2026RAPP
Rapport Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
15.2K shares- - Jun 17, 2025RAPP
Rapport Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
10.9K shares- - Nov 7, 2024RAPP
Rapport Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
29.8K shares-
1-3 of 3 transactions
About PEREZ ROBERT J
PEREZ ROBERT J (SEC CIK 0001263230) files insider reports with the SEC as Director of Rapport Therapeutics, Inc. (RAPP).
Signal8 holds 4 ownership filings by PEREZ ROBERT J (1 Form 3, 3 Form 4), filed between Nov 7, 2024 and Jun 10, 2026. Those filings report 3 transactions, from Nov 7, 2024 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on PEREZ ROBERT J's filings is in BOSTON, MA.
Recent filings by PEREZ ROBERT J
Other insiders filing for Rapport Therapeutics, Inc. (RAPP)
- HEALY JAMES, Director
- Ceesay Abraham, Chief Executive Officer
- Sanchez Ramiro, Director
- Silva Paul M, Director
- Young Wendy B., Director
- PAUL STEVEN M, Director